Related Experiment Video
Updated: May 5, 2026
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Home treatment of antibody-deficiency syndromes with intravenous immune globulin
R U Sorensen1, M D Kallick, M Berger
1Department of Pediatrics, Rainbow Babies and Childrens Hospital, Cleveland, Ohio.
Immune globulin replacement is a safe and effective therapy for patients with antibody-deficiency syndromes. The need for frequent hospital visits for treatment and high cost remain significant problems. To surmount these problems, we developed a program of patient/family-performed home administration of intravenous immune globulin. Fourteen patients were selected with predetermined eligibility criteria. Nine patients chose to enter the study. Patients and/or relatives were taught the technique of intravenous administration. A signed agreement to perform the infusion under physician instructions was required. All patients successfully performed home treatment, with an average of 19 infusions completed per patient (range 10 to 24). Home treatment decreased absence from work and school. Another benefit noted was a better self-image for patients who require life-long therapy. Regular follow-up visits with the physician are important for adequate care of patients. We conclude that home self-administration of intravenous immune globulin is feasible, safe, and effective in selected patients.
Immune globulin replacement is a safe and effective therapy for patients with antibody-deficiency syndromes. The need for frequent hospital visits for treatment and high cost remain significant problems. To surmount these problems, we developed a program of patient/family-performed home administration of intravenous immune globulin. Fourteen patients were selected with predetermined eligibility criteria. Nine patients chose to enter the study. Patients and/or relatives were taught the technique of intravenous administration. A signed agreement to perform the infusion under physician instructions was required. All patients successfully performed home treatment, with an average of 19 infusions completed per patient (range 10 to 24). Home treatment decreased absence from work and school. Another benefit noted was a better self-image for patients who require life-long therapy. Regular follow-up visits with the physician are important for adequate care of patients. We conclude that home self-administration of intravenous immune globulin is feasible, safe, and effective in selected patients.
Related Concept Videos
01:36Humoral Immune Responses
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:15Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:22Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:25Immunodeficiency Diseases
There are three main causes of immunodeficiency...